Title	Publication Date	Language	Citations
Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models	2004/06/01	English	122
Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes	2004/04/01	English	122
Platinum(II) and palladium(II) complexes with 2-acetylpyridine thiosemicarbazone: cytogenetic and antineoplastic effects	2001/01/01	English	119
Taxol	1991/12/01	English	114
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines	1996/06/01	English	111
Targeting CK2 for cancer therapy	2005/11/01	English	109
Non-viral vectors in cancer gene therapy: principles and progress	2001/04/01	English	108
Toxicity of anticancer agents mediated by electroporation in vitro	2000/03/01	English	108
Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects	2006/03/01	English	108
Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer	2006/04/01	English	104
Preclinical pharmacokinetics of paclitaxel and docetaxel	1998/01/01	English	104
Apoptosis-based drug screening and detection of selective toxicity to cancer cells	2003/08/01	English	103
Hsp90: an emerging target for breast cancer therapy	2004/08/01	English	102
Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients	2004/09/01	English	101
In vitro evaluation of temozolomide combined with X-irradiation	1997/01/01	English	100
Amifostine in clinical oncology: current use and future applications	2002/03/01	English	100
Isothiocyanates: mechanism of cancer chemopreventive action	2002/04/01	English	98
Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models	1999/11/01	English	97
Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]	1999/01/01	English	95
5-Substituted-2-thiohydantoin analogs as a novel class of antitumor agents	1996/11/01	English	94
The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor	1996/09/01	English	94
Tissue distribution, metabolism and excretion of paclitaxel in mice	1996/01/01	English	94
Hypoxia inducible factor-1: a novel target for cancer therapy	2005/10/01	English	94
Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action	2002/07/01	English	94
In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes	2005/11/01	English	93
Acquired tamoxifen resistance in human breast cancer–potential mechanisms and clinical implications	1997/11/01	English	92
Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane	2005/03/01	English	90
Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin	2000/09/01	English	88
A3 adenosine receptor as a target for cancer therapy	2002/06/01	English	88
Capecitabine: a novel agent for the treatment of solid tumors	2001/09/01	English	87